{
    "2018-09-10": [
        [
            {
                "time": "2018-09-10",
                "original_text": "Health Care Sector Update for 09/10/2018: MYOK, ACAD, MRK, FOLD, LLY",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "MYOK",
                        "ACAD",
                        "MRK",
                        "FOLD",
                        "LLY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Eli Lilly Initiates New Trial for Taltz in Plaque Psoriasis",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Taltz",
                        "Trial",
                        "Plaque Psoriasis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Health Care Sector Update for 09/10/2018: ACAD, MRK, FOLD",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "ACAD",
                        "MRK",
                        "FOLD"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Glaxo's Nucala Suffers Regulatory Setback, Gets CRL for COPD",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Nucala",
                        "Regulatory Setback",
                        "COPD"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Lilly to Showcase New Data at the 27th European Academy of Dermatology and Venereology (EADV) Congress, Furthering Innovation for Patients with Complex Dermatological Conditions",
                "features": {
                    "keywords": [
                        "Lilly",
                        "EADV",
                        "Data",
                        "Dermatology",
                        "Innovation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Lilly (LLY) Hits 52-Week High, Can the Run Continue?",
                "features": {
                    "keywords": [
                        "Lilly",
                        "LLY",
                        "52-Week High"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Glaxo's Nucala Suffers Regulatory Setback, Gets CRL for COPD",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Nucala",
                        "Regulatory Setback",
                        "COPD"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz® and Tremfya® in Patients with Moderate-to-Severe Plaque Psoriasis",
                "features": {
                    "keywords": [
                        "Lilly",
                        "IXORA-R",
                        "Taltz",
                        "Tremfya",
                        "Plaque Psoriasis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}